KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 77 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2018 | $52,000 | +62.5% | 5,650 | +197.4% | 0.00% | +200.0% |
| Q3 2018 | $32,000 | +3.2% | 1,900 | +5.6% | 0.00% | 0.0% |
| Q2 2018 | $31,000 | +3000.0% | 1,800 | +1100.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 150 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | +100.0% | 150 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -75.0% | 150 | -76.9% | 0.00% | – |
| Q2 2016 | $4,000 | -42.9% | 650 | +30.0% | 0.00% | – |
| Q4 2015 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |